Public list Pharma Startups (6570):
Gracell Bio (NASDAQ: GRCL) is a clinical-stage biopharmaceutical company dedicated to discovering and developing cellular therapeutics for patients suffered from hematological malignancy, a solid tumor, or degenerative disease.
Company (IPO / Went public)
12th Floor, 926 Yishan Road
Xu Hui District
|Investor||Investor Type||Location||Participating Rounds|